
Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions
Keywords: موتاژنز; IDO; Indoleamine 2,3-dioxygenase; Molecular modeling; Drug screening; Inhibitors; Mutagenesis; ACSRC; Auckland Cancer Society Research Centre; BF; benzofurazan; C129A; alanine-replacement IDO1 mutant of Cys129; GSH; reduced glutathione; IDO1; indoleamine